Monday, May 5, 2008 , Updated
Dallas-based Access Pharmaceuticals featured in investment book
DALLAS — Access Pharmaceuticals announced today that renowned business columnist and author Gene Marcial of BusinessWeek has highlighted Access Pharmaceuticals in his recently released investing book titled "7 Commandments of Stock Investing." In a section pertaining to his sixth commandment of "not fearing the unknown," Mr. Marcial includes Access Pharmaceuticals as one of three "unrecognized attractive biotechs" that are not widely followed by Wall Street but "whose prospects look tantalizing because of their huge potential value." Included in the analysis is commentary on Access' ProLindac, its proprietary second-generation DACH platinum drug that is being developed to target the markets currently being served by Sanofi-Aventis' Eloxatin, and on MuGard, Access' FDA-approved treatment for oral mucositis. Gene Marcial has been BusinessWeek's "Inside Wall Street" columnist for the past 26 years, and is a former columnist at the Wall Street Journal.
Source: Access Pharmaceuticals
Email
|
Print
|
Comment
|
Tell us your story
|
- »DISH at Ilume bringing chic dining to Cedar Springs in Dallas
- »Savor Dallas adds recipes and chef demos to website
- »Photo gallery: Crowds gather in Dealey Plaza to remember John F. Kennedy assassination
- »Photo gallery: Late Nights at the DMA (November 20)
- »Video: Booker T. Washington Senior Art Show
-
»Changing jobs in Dallas-Fort Worth? Know your options
-
»Behringer Harvard expands management team
-
»Texas Instruments Senior VP to deliver keynote speech at Lehman Brothers investor conference
-
»TCU's Investor Challenge nets hard cash scholarships for talented virtual portfolio investors
-
»Investing site Motley Fool trades on stereotypes in its evaluation of Dallas
|
an event
|
a restaurant
|
|
a garage sale
|
a drink special
|
|
a movie showtime
|
local music
|
a job
|
a house
|
|
a deal
|
a pet
|
